The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

The Senate Finance Committee will meet on Jan. 29 to discuss the confirmation of RFK Jr., whose stances on vaccines and abortion have raised questions from Democrats and Republicans alike.

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The rescinded Biden-era orders include actions to boost the Affordable Care Act exchanges, coordinate the government’s ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the Inflation Reduction Act.